GLP-1s may weaken the pelvic floor, impacting women's health – and their sex lives

Rapid weight loss and constipation from GLP-1 drugs may cause pelvic floor dysfunction and vaginal symptoms, with up to 50% of chronic constipation patients affected, experts say.